Studies involving disease:Diabetes
Study ID | Study Title | Species | Institute |
---|---|---|---|
ST000048 | Metabolomic & lipidomic profiles in response to exogenous insulin & GLP-1 infusions during prolonged fasting (GCMS) | Seal | University of California, Davis |
ST000057 | Combined Metabolomics and Lipidomics of Type 1 Diabetes (GCMS) | Mouse | University of California, Davis |
ST000075 | Combined Metabolomics and Lipidomics of Type 1 Diabetes (QTOF) | Mouse | University of California, Davis |
ST000091 | Quantitative Metabolomics by 1H-NMR and LC-MS/MS Confirms Altered Metabolic Pathways in Diabetes | Human | Mayo Clinic |
ST000107 | Metabolomic and lipidomic profiles in response to exogenous insulin and GLP-1 infusions during prolonged fasting | Seal | University of California, Davis |
ST000115 | Impact of insulin deprivation and treatment on sphingolipid distribution in different muscle subcellular compartments of streptozotocin-diabetic C57Bl/6 mice | Mouse | Mayo Clinic |
ST000149 | High Insulin Combined With Essential Amino Acids Stimulates Skeletal Muscle Mitochondrial Protein Synthesis While Decreasing Insulin Sensitivity in Healthy Humans | Human | Mayo Clinic |
ST000164 | Metabolomic analysis of normal and diabetic mouse bone marrow under PBS or metformin treatment | Mouse | New York University |
ST000168 | Effect of Insulin Sensitizer Therapy on Amino Acids and Their Metabolites | Human | Mayo Clinic |
ST000347 | Metabolomic analysis on samples from rats expressing human amylin (cardiac tissue). | Rat | Duke University |
ST000348 | Metabolomic analysis on samples from rats expressing human amylin (brain tissue). | Rat | Duke University |
ST000349 | Metabolomic analysis on samples from rats expressing human amylin (hepatic tissue). | Rat | Duke University |
ST000350 | Metabolomic analysis on samples from rats expressing human amylin (plasma). | Rat | Duke University |
ST000383 | Plasma Metabolomic Profiles Reflective of Glucose Homeostasis in Non-Diabetic and Type 2 Diabetic Obese African-American Women | Human | University of California, Davis |
ST000398 | Metabolic profiling of maternal urine can aid clinical management of Gestational Diabetes Mellitus (GDM) | Human | University of Aveiro |
ST000421 | Type 1 Diabetes poor glycemic control versus control samples | Human | Mayo Clinic |
ST000422 | Type 1 Diabetes good glycemic control and controls samples | Human | Mayo Clinic |
ST000432 | Quantitative measurements of vitamin D in T1D poor control, good control, and controls. | Human | Mayo Clinic |
ST000434 | Quantitative measurements of free fatty acid in T1D poor control, good control, and controls. | Human | Mayo Clinic |
ST000435 | Quantitative measurements of amino acids in T1D poor control, good control, and controls. | Human | Mayo Clinic |
ST000443 | Quantitative measurements of TCA cycle metabolites in T1D poor control, good control, and controls. | Human | Mayo Clinic |
ST000467 | Metabolomics of Saliva Samples Obtained from Subjects with Diabetes | Human | University of North Carolina |
ST000511 | Determine how inhibition of autophagy/proteasome degradation or inhibition of protein synthesis in models of muscle insulin resistance affect amino acid metabolites | Mouse | Mayo Clinic |
ST000512 | Investigating TCA concentrations in mice muscle tissue lacking insulin receptors and IGF-1 receptors | Mouse | Mayo Clinic |
ST000513 | Inhibition of autophagy/proteasome degradation or inhibition of protein synthesis in models of muscle insulin resistance affect TCA cycle | Mouse | Mayo Clinic |
ST000514 | Inhibition of autophagy/proteasome degradation or inhibition of protein synthesis in models of muscle insulin resistance affect amino acids metabolites in serum | Mouse | Mayo Clinic |
ST000516 | Measuring amino acid metabolites in insulin resistant and insulin deficient mouse tissue models | Mouse | Mayo Clinic |
ST000517 | Measuring acylcarnitine concentrations in insulin resistant and insulin deficient mouse tissue models | Mouse | Mayo Clinic |
ST000518 | Measuring ceramide concentrations in insulin resistant and insulin deficient mouse tissue models | Mouse | Mayo Clinic |
ST000519 | Investigating ceremide concentrations in mice muscle tissue lacking insulin receptors and IGF-1 receptors | Mouse | Mayo Clinic |
ST000520 | Measuring TCA cycle concentrations in insulin resistant and insulin deficient mouse tissue models | Mouse | Mayo Clinic |
ST000521 | Measuring NEFA concentrations in insulin resistant and insulin deficient mouse tissue models | Mouse | Mayo Clinic |
ST000530 | Effects of herb DG and KK01 on Type 2 Diabetes Mellitus (T2DM) through Lipidomics | Mouse | University of North Carolina |
ST000540 | Kidney tissue metabolomic profiling of diabetic nephropathy in the steptozotocin induced type-1 diabetes mouse model. | Mouse | RTI International |
ST000541 | Canine Diabetes - Preliminary Evaluation of Testing Methods | Dog | University of Florida |
ST000549 | Investigating large scale metabolomics in mice serum lacking insulin receptors and IGF-1 receptors | Mouse | Mayo Clinic |
ST000551 | Investigating large scale metabolomics in mice tissue lacking insulin receptors and IGF-1 receptors | Mouse | Mayo Clinic |
ST000558 | Plasma metabolomic profiling of diabetic nephropathy in the steptozotocin induced type-1 diabetes mouse model | Mouse | RTI International |
ST000559 | Urine metabolomic profiling of diabetic nephropathy in the steptozotocin induced type-1 diabetes mouse model. | Mouse | RTI International |
ST000568 | Metabolomic study on a schizophrenia and type 2 diabetes susceptibility gene | Human | Shanghai Jiao Tong University Affiliated Sixth People’s Hospital |
ST000640 | Targeted NEFA in American Indian Adolescents (part I) | Human | Mayo Clinic |
ST000641 | Targeted Amino Acids in American Indian Adolescents (part II) | Human | Mayo Clinic |
ST000667 | Diabetic Microvascular Plasma/Tissue Lipidomics- Comparison | Mouse | University of Michigan |
ST000672 | Diabetic Microvascular Plasma/Tissue Lipidomics- Comparison (part II) | Mouse | University of Michigan |
ST000691 | Metabolomics of diabetic nephropathy | Human | University of Michigan |
ST000712 | Diabetic heart adrenergic signaling and metabolism (STZ & Isoproterenol, High Fat) | Mouse | University of Michigan |
ST000743 | Metabolomics of bariatric weight loss | Human | University of Michigan |
ST000744 | Metabolomics of intensive weight management clinic (IWMC) weight loss | Human | University of Michigan |
ST000816 | Lipidomics of Chronic Kidney Disease progression | Human | University of Michigan |
ST000829 | 12 weeks control & STZ B6 mice retina & plasma amino acid analysis | Mouse | University of Michigan |
ST000840 | Diabetic heart adrenergic signaling and metabolism (STZ & Isoproterenol, High Fat) - part II | Mouse | University of Michigan |
ST001135 | Different dose exposure of OPC-163493 on HepG2 cells (part-I) | Human | Otsuka Pharmaceutical Co., Ltd. |
ST001136 | Metabolme analysis of OPC-163493 on the Liver of ZDF rats (part-II) | Rat | Otsuka Pharmaceutical Co., Ltd. |
ST001145 | UPLC-MS Analysis of Lipids From Insulin Resistant Femoral Muscles of Diet-induced Obese Mice | Mouse | Colorado State University |
ST001249 | Biliary diversion fecal extractions | Mouse | Vanderbilt University |
ST001253 | Phenotyping Mouse blood metabolites in day and night in type 2 diabetes | Mouse | Indiana University School of Medicine |
ST001266 | Metabolomic Profiles of Pancreatic β-Cells and Islets Exposed to Arsenic, part I β-Cells | Mouse | University of North Carolina |
ST001292 | Metabolomics of blood plasma and kidney tissue from control (db/m) and diabetic (db/db) mice. | Mouse | University of Michigan |
ST001314 | Metabolomic Profiles of Pancreatic β-Cells and Islets Exposed to Arsenic, Islets (part-II) | Mouse | University of North Carolina at Chapel Hill |
ST001386 | TEDDY Metabolomics Study | Human | University of South Florida |
ST001436 | Transkingdom interactions between Lactobacilli and hepatic mitochondria attenuate western diet induced diabetes | Mouse | Oregon State University |
ST001636 | TEDDY Lipidomics Study | Human | University of South Florida |
ST001642 | Lipidomics in high-risk subjects for the identification of integrated biomarker signatures of type 1 diabetes | Human | University of Miami |
ST001643 | Deletion of the diabetes candidate gene Slc16a13 in mice | Mouse | University of California, Davis |
ST001690 | Untargeted metabolomic analysis of human blood samples via qualitative GC-MS for T1D biomarker identification | Human | Duke University |
ST001754 | Metabolomic Analysis of Canine Diabetes (part-II) | Dog | University of Florida |
ST001796 | Changes in mesenteric lymph lipid profile of mice upon high-fat diet with and without Celecoxib | Mus musculus | Monash Institute of Pharmaceutical Sciences |
ST001905 | Metabolomic profiling of saliva in diabetes patients | Human | Osaka University |
ST001906 | Metabolomic profiling of plasma in diabetes patients | Human | Osaka University |
ST001932 | Perfluorinated compounds and high fat diet in relation to CVD-relevant metabolomic pathways in the SEARCH for Diabetes in Youth study | Human | Emory University |
ST001935 | Metabolomic profiling of spontaneous macaque model for diabetes mellitus | Macaque monkey | Xiamen University |
ST001948 | Metabolites Associated with Gestational Diabetes in Plasma | Human | California Polytechnic State University |
ST001953 | Identifying metabolite changes in human islets treated with Phospho-BAD mimicry and Inflammatory cytokines | Human | Harvard University |
ST001959 | Investigation of serum metabolites in the AMPK intestinal KO mice | Mouse | City of Hope National Medical Center |
ST001991 | Dynamics of bile acid metabolism between the host and gut microbiome in progression to islet autoimmunity (Blood) | Human | University of Turku |
ST001992 | Dynamics of bile acid metabolism between the host and gut microbiome in progression to islet autoimmunity (Feces) | Human | University of Turku |
ST002119 | Metabolomics analysis of zebrafish response to CID661578 treatment | Zebrafish | North Carolina State University |
ST002145 | The Carbohydrate Sensing Transcription Factor ChREBP Links Mitochondrial Lipidomes to Mitochondrial Dynamics and Progression of Diabetic Nephropathy | Mouse | University of Texas MD Anderson Cancer Center |
ST002161 | Glycerate Production from Intestinal Fructose Metabolism Elevated by Dietary Fat Induces Glucose Intolerance Through β-cell Damage | Mouse | Duke University |
ST002204 | Endothelial Sirtuin1 Suppresses Whole-body Insulin Sensitivity by Modulating the Secretome | Mouse | University of Iowa |
ST002268 | Autophagy-related protein PIK3C3 maintains healthy brown and white adipose tissues to prevent metabolic diseases | Mouse | Vanderbilt University |
ST002382 | Deep multi-omic profiling reveals extensive mitochondrial remodeling driven by glycemia in early diabetic kidney disease | Rat | University of Melbourne |
ST002474 | Retinol Dehydrogenase 10 Reduction Mediated Retinol Metabolism Disorder Promotes Diabetic Cardiomyopathy in Male Mice. | Mouse | Zhongshan School of Medicine, Sun Yat-sen University |
ST002496 | Study of environmental toxicants and gut microbiome in relation to obesity and insulin resistance | Human | Örebro University |
ST002524 | In situ microwave fixation provides an instantaneous snapshot of the brain metabolome - Part 1 | Mouse | University of Florida |
ST002525 | In situ microwave fixation provides an instantaneous snapshot of the brain metabolome - Part 2 | Mouse | University of Florida |
ST002540 | Deriving Schwann Cells from hPSCs Enables Disease Modeling and Drug Discovery for Diabetic Peripheral Neuropathy | Human | University of California, San Francisco |
ST002561 | Metabolomic profiling of PMM2-CDG zebrafish in presence and absence of epalrestat | Zebrafish | Mayo Clinic |
ST002562 | Metabolomic profiling of PMM2-CDG patient fibroblasts in presence and absence of epalrestat | Human | Mayo Clinic |
ST002563 | Metabolomic profiling of PMM2-CDG after siRNA mediated KD of AKR1b1 | Human | Mayo Clinic |
ST002564 | Metabolomic profiling of PMM2-CDG after siRNA mediated KD of AKR1b1 and neuraminidase treatment | Human | Mayo Clinic |
ST002565 | Metabolomic profiling of PMM2-CDG after siRNA mediated KD of AKR1b1 - 13C6 glucose and fructose study | Human | Mayo Clinic |
ST002566 | Metabolomic profiling of PMM2-CDG patient fibroblasts | Human | Mayo Clinic |
ST002567 | Metabolomics of Human islets treated with DHT and high-glucose challenge | Human | Tulane University School of Medicine |
ST002575 | Metabolomic profiling of PMM2-CDG patient fibroblasts by GC/MS | Human | Mayo Clinic |
ST002681 | Non-T2D vs T2D | Human | University of Colorado Anschutz Medical Campus |
ST002729 | Improved Endurance Capacity of Diabetic Mice during SGLT2 Inhibition: Potential Role of AICARP, an Endogenous AMPK Activator. | Mouse | Medical Institute of Bioregulation, Kyushu University |
ST002735 | Untargeted metabolomics revealed multiple metabolic perturbations in plasma of T2D patients in response to Liraglutide | Human | King Faisal Specialist Hospital and Research Centre (KFSHRC) |
ST002814 | Atlas of fetal metabolism during mid-to-late gestation and diabetic pregnancy | Mouse | University of California, Los Angeles |
ST002878 | Atlas of fetal metabolism during mid-to-late gestation and diabetic pregnancy. Dynamic Labelling experiment. | Mouse | University of California, Los Angeles |
Return to search page